Clinical Trials Browser

Phase 1 × pasireotide × Endocrine × Clear all

NCT01469572 2018-10-18

Pasireotide, Everolimus and Selective Internal Radioembolization Therapy for Unresectable Hepatic Metastases

Phase 1 Completed

EndocrineGastrointestinalNET

Liver Neoplasms, Neuroendocrine Tumors

NCT00804336 2016-10-19

Pasireotide in Combination With RAD001 in Patients With Advanced Neuroendocrine Tumors

Phase 1 Completed

Carcinoid Tumor, Adenoma, Islet Cell, Neuroendocrine Tumors